Amesite Stock Soars 53% on Launch of NurseMagicAI Enterprise

Introduction

AMESITE INC (NASDAQ: AMST) is an artificial intelligence-driven software company headquartered in Ann Arbor, Michigan. Its flagship product, NurseMagic™, automates clinical documentation for care professionals, reducing note-taking time from 20 minutes to approximately 20 seconds. As of September 11, 2025, AMST shares traded at $4.11 on the NASDAQ, reflecting a 53.36% increase, with a trading volume of approximately 8.3 million shares.

Corporate Structure

Founded in 2018, Amesite operates with approximately 11 to 50 employees. Ann Marie Sastry, Ph.D., serves as President, Chief Executive Officer, and Chairman. She co-founded Sakti3 and previously held the title of Arthur F. Thurnau Professor at the University of Michigan. Sarah Berman, a Certified Public Accountant, is the Principal Accounting and Finance Officer, bringing experience in auditing and advisory services for both public and private companies. Brandon Owens, Vice President of Sales, manages enterprise revenue strategy and investor communications, having held roles at Pluralsight and AT&T.

NurseMagic by Birmingham Museums Trust

Developments and News

On June 26, 2025, Amesite filed a Form 8-K disclosing items 4.01 and 9.01, which provide updates on its corporate events and financial condition. The company also submitted its Form 10-Q for the quarter ended March 31, 2025, on May 15, 2025. In July 2025, Amesite launched NurseMagicAI Enterprise, which includes integration with electronic medical records, automation for interdisciplinary teams, and a census-based pricing model. Additionally, on July 4, 2025, the platform introduced AI-powered charting in 16 languages.

Financial and Strategic Analysis

Amesite targets an addressable market of approximately $330 billion across home and healthcare sectors. Relevant market metrics indicate there are 5.2 million U.S. registered nurses and 3.9 million home health and personal care aides, within a $190 billion home healthcare provider market and a $130 billion home care segment. While the June 26 8-K did not provide detailed revenue figures, the company focuses on enterprise subscription growth, product enhancements, and workflow integrations. Its proprietary AI platform meets HIPAA standards and serves both business and individual users across all 50 states and in 21 countries.

Market Position and Industry Context

Operating at the intersection of healthcare IT and educational technology, Amesite competes with vendors providing clinical documentation and online learning solutions. NurseMagic addresses industry challenges such as documentation burden, claim rejections, and staff turnover. The company's visibility in the market is reflected in coverage by various media outlets, including Forbes, Business Insider, CNBC, Bloomberg, Fox Business, and Yahoo Finance.

tl;dr

As of September 11, 2025, AMST shares traded at $4.11 (+53.36%) with approximately 8.3 million shares traded. The company filed an 8-K on June 26, 2025, and a Form 10-Q on May 15, 2025. In July 2025, it introduced NurseMagicAI Enterprise featuring EMR integration, census-based pricing, and interdisciplinary automation, along with expanded charting in 16 languages. Amesite is positioned to grow enterprise subscriptions and enhance workflow integrations within a $330 billion home and healthcare market.